Company intelligence / Profile preview

Trucan Diagnostics

Bangalore, Karnataka, Indiain.linkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Trucan Diagnostics is developing and clinically validating advanced, next-generation sequencing and biomarker-driven diagnostic tests for early cancer detection, therapy response prediction, personalized treatment planning, and real-time monitoring. Their partnership with HealthCare Global Enterprises aims to generate real-world evidence supporting clinical adoption in India. No published clinical trial results yet; validation studies are underway as of late 2024.

Therapeutic areas: Oncology
Modalities: Device (diagnostic tests)Next-generation sequencing-based diagnosticsBiomarker-driven diagnostics
Industry: Molecular Diagnostics

Partnerships

HealthCare Global Enterprises Limited (HCG)Triesta Genomics Laboratories

Beyond the preview

Go deeper on Trucan Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trucan Diagnostics.

Explore the full profile